Fig. 1

Quarterly Rates of HBOC, Lynch Syndrome, Tier 2 Molecular Pathology Procedures^*, and Any^** Cancer Genetic Testing in Enrollees of Medicare, Commercial, Medicaid and State Employee Plans. HBOC – Hereditary Breast and Ovarian Cancer. * Tier 2 molecular pathology procedures are based on the complexity of the testing technique and are not specific to a gene or hereditary cancer syndrome. ** Any cancer genetic testing included tests in the HBOC, Lynch syndrome, Tier 2 molecular pathology procedures, and other hereditary cancer syndrome (HCS) panel categories